Last Updated: May 23, 2026

Drug Price Trends for NDC 51248-0151


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 51248-0151

Drug Name NDC Price/Unit ($) Unit Date
VESICARE 10 MG TABLET 51248-0151-01 12.30639 EACH 2026-05-20
VESICARE 10 MG TABLET 51248-0151-01 12.29238 EACH 2026-04-22
VESICARE 10 MG TABLET 51248-0151-01 12.30313 EACH 2026-03-18
VESICARE 10 MG TABLET 51248-0151-01 12.30313 EACH 2026-02-18
VESICARE 10 MG TABLET 51248-0151-01 12.29269 EACH 2026-01-21
VESICARE 10 MG TABLET 51248-0151-01 12.29861 EACH 2025-12-17
VESICARE 10 MG TABLET 51248-0151-01 12.31252 EACH 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 51248-0151

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-01 30 219.11 7.30367 2021-09-30 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-01 30 230.91 7.69700 2022-01-01 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-01 30 249.85 8.32833 2023-01-01 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-01 30 282.04 9.40133 2024-01-01 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-03 90 654.57 7.27300 2021-09-30 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-03 90 689.86 7.66511 2022-01-01 - 2026-09-29 FSS
VESICARE 10MG TAB Astellas Pharma U.S., Inc. 51248-0151-03 90 746.43 8.29367 2023-01-01 - 2026-09-29 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.